Investigation of the applicability of dry powder inhalation in children with cystic fibrosis

Investigation of the applicability of dry powder inhalation in children with cystic fibrosis - Dry powder inhalation in children with CF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40571

Enrollment

Registered

2014-04-28

Start date

2014-05-22

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cystic fibrosis mucoviscidosis

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: - A physician*s diagnosis of CF - 4 to 14 years of age - Informed consent from the parent(s)/guardian(s) - Assent from the child (informed consent when >=12 years of age)

Exclusion criteria

Exclusion criteria: No exclusion criteria are formulated.

Design outcomes

Primary

Measure	Time frame
The main study parameter is the ability of a child to achieve a proper inhalation manoeuvre with the test inhaler, which is reflected in the pressure drop they create over the inhaler upon inhalation.	—

Secondary

Measure	Time frame
From the (duration of the) pressure drop, various inspiratory parameters will be calculated per airflow resistance. The incidence of obstructions in the oral cavity upon inhalation will be expressed as percentage of the total number of observations.	—

Countries

Netherlands

Outcome results